Expression and roles of keratinocyte growth factor and its receptor in esophageal cancer cells

International Journal of Oncology

Volumn 31, Issue 4, 2007, Pages 721-728

  Yoshino, Masanori ^a   Ishiwata, Toshiyuki ^a   Watanabe, Masanori ^a   Matsunobu, Tetsuro ^a   Komine, Osamu ^a   Ono, Yuri ^a   Yamamoto, Tetsushi ^a   Fujii, Takenori ^a   Matsumoto, Koshi ^a   Tokunaga, Akira ^a   Naito, Zenya ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Esophageal cancer; Immunohistochemistry; Keratinocyte growth factor receptor fibroblast growth factor receptor 2 IIIb; Keratinocyte growth factor fibroblast growth factor 7

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 2; KERATINOCYTE GROWTH FACTOR; KERATINOCYTE GROWTH FACTOR RECEPTOR; KI 67 ANTIGEN; TUMOR MARKER;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER STAGING; CELL DIFFERENTIATION; EPITHELIUM CELL; ESOPHAGUS TUMOR; FEMALE; HUMAN; LYMPH NODE METASTASIS; MALE; METABOLISM; METASTASIS; MIDDLE AGED; PATHOLOGY; PROGNOSIS; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; WESTERN BLOTTING;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; EPITHELIAL CELLS; ESOPHAGEAL NEOPLASMS; FEMALE; FIBROBLAST GROWTH FACTOR 7; HUMANS; KI-67 ANTIGEN; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 35848969343     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.31.4.721     Document Type: Article

References (30)

1. Itoh N and Ornitz DM: Evolution of the Fgf and Fgfr gene families. Trends Genet 20: 563-569, 2004.
2. Ornitz DM and Itoh N: Fibroblast growth factors. Genome Biol 2: Reviews S3005, 2001.
3. Miki T, Bottaro DP, Fleming TP, et al: Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene. Proc Natl Acad Sci USA 89: 246-250, 1992.
4. Mohammadi M, Olsen SK and Ibrahimi OA: Structural basis for fibroblast growth factor receptor activation. Cytokine Growth Factor Rev 16: 107-137, 2005.
5. Igarashi M, Finch PW and Aaronson SA: Characterization of recombinant human fibroblast growth factor (FGF)-10 reveals functional similarities with keratinocyte growth factor (FGF-7). J Biol Chem 273: 13230-13235, 1998.
6. De Moerlooze L, Spencer-Dene B, Revest J, Hajihosseini M, Rosewell I and Dickson C: An important role for the IIIb isoform of fibroblast growth factor receptor 2 (FGFR2) in mesenchymal-epithelial signalling during mouse organogenesis. Development 127: 483-492, 2000.
7. Revest JM, Spencer-Dene B, Kerr K, De Moerlooze L, Rosewell I and Dickson C: Fibroblast growth factor receptor 2-IIIb acts upstream of Shh and Fgf4 and is required for limb bud maintenance but not for the induction of Fgf8, Fgf10, Msx1, or Bmp4. Dev Biol 231: 47-62, 2001.
8. Xu X, Weinstein M, Li C, et al: Fibroblast growth factor receptor 2 (FGFR2)-mediated reciprocal regulation loop between FGF8 and FGF10 is essential for limb induction. Development 125: 753-765, 1998.
9. Housley RM, Morris CF, Boyle W, et al: Keratinocyte growth factor induces proliferation of hepatocytes and epithelial cells throughout the rat gastrointestinal tract. J Clin Invest 94: 1764-1777, 1994.
10. Visco V, Belleudi F, Marchese C, et al: Differential response to keratinocyte growth factor receptor and epidermal growth factor receptor ligands of proliferating and differentiating intestinal epithelial cells. J Cell Physiol 200: 31-44, 2004.
11. Baatar D, Kawanaka H, Szabo IL, et al: Esophageal ulceration activates keratinocyte growth factor and its receptor in rats: implications for ulcer healing. Gastroenterology 122: 458-468, 2002.
12. Ishiwata T, Friess H, Buchler MW, Lopez ME and Korc M: Characterization of keratinocyte growth factor and receptor expression in human pancreatic cancer. Am J Pathol 153: 213-222, 1998.
13. Otte JM, Schmitz F, Banasiewicz T, Drews M, Folsch UR and Herzig KH: Expression of keratinocyte growth factor and its receptor in colorectal cancer. Eur J Clin Invest 30: 222-229, 2000. (Pubitemid 30153663)
14. Yoshino M, Ishiwata T, Watanabe M, et al: Keratinocyte growth factor receptor expression in normal colorectal epithelial cells and differentiated type of colorectal cancer. Oncol Rep 13: 247-252, 2005.
15. Siddiqi I, Funatomi H, Kobrin MS, Friess H, Buchler MW and Korc M: Increased expression of keratinocyte growth factor in human pancreatic cancer. Biochem Biophys Res Commun 215: 309-315, 1995.
16. Dignass AU, Tsunekawa S and Podolsky DK: Fibroblast growth factors modulate intestinal epithelial cell growth and migration. Gastroenterology 106: 1254-1262, 1994.
17. Nakazawa K, Yashiro M and Hirakawa K: Keratinocyte growth factor produced by gastric fibroblasts specifically stimulates proliferation of cancer cells from scirrhous gastric carcinoma. Cancer Res 63: 8848-8852, 2003.
18. Iida S, Katoh O, Tokunaga A and Terada M: Expression of fibroblast growth factor gene family and its receptor gene family in the human upper gastrointestinal tract. Biochem Biophys Res Commun 199: 1113-1119, 1994.
19. Oelmann E, Haghgu S, Kulimova E, et al: Influence of keratinocyte growth factor on clonal growth of epithelial tumor cells, lymphoma and leukemia cells and on sensitivity of tumor cells towards 5-fluorouracil in vitro. Int J Oncol 25: 1001-1012, 2004.
20. Ropiquet F, Huguenin S, Villette JM, et al: FGF7/KGF triggers cell transformation and invasion on immortalised human prostatic epithelial PNT1A cells. Int J Cancer 82: 237-243, 1999.
21. Zhang Y, Wang H, Toratani S, et al: Growth inhibition by keratinocyte growth factor receptor of human salivary adenocarcinoma cells through induction of differentiation and apoptosis. Proc Natl Acad Sci USA 98: 11336-11340, 2001.
22. Spielberger R, Stiff P, Bensinger W, et al: Palifermin for oral mucositis after intensive therapy for hematologic cancers. N Engl J Med 351: 2590-2598, 2004.
23. Finch PW and Rubin JS: Keratinocyte growth factor expression and activity in cancer: implications for use in patients with solid tumors. J Natl Cancer Inst 98: 812-824, 2006.
24. Rosen LS, Abdi E, Davis ID, et al: Palifermin reduces the incidence of oral mucositis in patients with metastatic colorectal cancer treated with fluorouracil-based chemotherapy. J Clin Oncol 24: 5194-5200, 2006.
25. Ishiwata T, Naito Z, Lu YP, et al: Differential distribution of fibroblast growth factor (FGF)-7 and FGF-10 in L-arginine-induced acute pancreatitis. Exp Mol Pathol 73: 181-190, 2002. (Pubitemid 38367365)
26. Kurban G, Ishiwata T, Kudo M, Yokoyama M, Sugisaki Y and Naito Z: Expression of keratinocyte growth factor receptor (KGFR/FGFR2 IIIb) in human uterine cervical cancer. Oncol Rep 11: 987-991, 2004.
27. Matsunobu T, Ishiwata T, Yoshino M, et al: Expression of keratinocyte growth factor receptor correlates with expansive growth and early stage of gastric cancer. Int J Oncol 28: 307-314, 2006.
28. Cho K, Ishiwata T, Uchida E, et al: Enhanced expression of keratinocyte growth factor and its receptor correlates with venous invasion in pancreatic cancer. Am J Pathol (in press).
29. Hattori Y, Itoh H, Uchino S, et al: Immunohistochemical detection of K-sam protein in stomach cancer. Clin Cancer Res 2: 1373-1381, 1996.
30. Zang XP and Pento JT: Keratinocyte growth factor-induced motility of breast cancer cells. Clin Exp Metastasis 18: 573-580, 2000. (Pubitemid 32964319)